Procaps Group SA (PROC) Net Sales Margin

Symbol and logo of brand Procaps Group SA (PROC)

Procaps Group S.A. (PROC) is fighting for market share amid internal conflicts and declining capsule profitability. Target net margins highlight these challenges, where the level of 0.00 reflects the current magnitude. This trend is driven by the high cost of CDMO plants and the expenses associated with implementing "green chemistry" in Latin America to comply with environmental regulations.

Procaps Group S.A. (PROC) - Net Sales Margin from 07/04/2022 to 02/16/2025

Summary analytical data breakdowns for Procaps Group S.A. (PROC)

- market value and analyst target forecast:
Summary company analytics:procapsgroup.com - PROC
Manufactured product of Procaps Group Corp

Procaps Group S.A. is scaling its drug production through high-tech softgel manufacturing facilities. Sales margins reflect the share of net profit in every euro earned, demonstrating the efficiency of B2B contracts. This metric measures the business's ability to convert revenue into actual income after all expenses. By analyzing the net profit margin on GURU.Markets, an investor can identify abnormal deviations from average values, which helps avoid purchasing an overheated asset at the peak of euphoria.

Competitors of Procaps Group S.A.

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin veronapharma.com|Net Return on Sales MENS (Jyong Biotech Corp)|Net Margin Ligand (LGND)|Net Sales Margin amneal.com (AMRX)|Net Sales Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Net Margin|Liquidia Inc. - Net Sales Margin|Net Profitability Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Net Margin|Net Return on Sales MNKD|Net Margin Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Company Sales Margin|Net Sales Margin SPRY|TBPH - Net Margin|Aquestive Pharma - Return on Sales by Net Profit|Net Sales Margin scpharmaceuticals.com SCPH|Tectonic - Net Sales Margin|TNXP - Net Sales Margin|SXTC: Net Sales Margin|Eupraxia Pharma - Net Profit Rate|BHST (bioharvest.com) - Net Sales Margin|Net Return on Sales EXOZ (invizyne.com)|Net Sales Margin ORMP|Company Sales Margin Entera Bio|Net Sales Margin HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Net Margin|Cumberland Corp - Net Sales Margin|QNTM - Net Sales Margin|FibroGen, Inc. (FGEN) - Net Margin|TELO: Company Net Profitability|RANI (Rani Therapeutics Inc) - Net Sales Margin|Net Margin synergychc.com SNYR|Net Margin Rallybio Corp. (RLYB)|LEXX - Net Margin|Net Sales Margin PULM (pulmatrix.com)|Company Net Profitability PTHL (Pheton)|APM - Net Margin|Company Sales Margin Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Net Margin|TNF Pharma (TNFA) - Net Sales Margin|YCBD (cbdmd.com) - Net Sales Margin|Return on Sales by Net Profit PainReform (PRFX)|Net Margin Altamira Therapeutics (CYTO)|Company Sales Margin Lipella Pharma|Optinose - Return on Sales by Net Profit|Company Sales Margin pieris.com (PIRS)|PTPI - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma